APcK110
Product Specifications
Target
Others|||c-Kit
Related Pathways
Tyrosine Kinase/Adaptors|||Others
Bioactivity
APcK110 is a novel Kit inhibitor . APcK110 inhibits proliferation of the mastocytosis cell line HMC1.2 and the SCF-responsive cell line OCI/AML3 in a dose-dependent manner . APcK110 is a more potent inhibitor of OCI/AML3 proliferation than the clinically used Kit inhibitors imatinib and dasatinib and at least as potent as cytarabine. APcK110 inhibits the phosphorylation of Kit, Stat3, Stat5, and Akt in a dose-dependent fashion, showing activity of APcK110 on Kit and its downstream signaling pathways . APcK110 may have potent application in AML.
Smiles
FC1=CC=C(C=2C=3C(=NC(=CC3)C4=CC(OC)=CC(OC)=C4)NN2)C=C1
Molecular Formula
C20H16FN3O2
Molecular Weight
349.36
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/34D171E9-ED36-4570-B317-B3AA8BB4755B/T71654
CAS Number
1001083-74-4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6239679-01 0.1 mL
NR1D1 (Nuclear Receptor Subfamily 1, Group D, Member 1, EAR1, THRA1, THRAL, ear-1, hRev) (MaxLight 750)
Ask
View Details 
MBS6239679-02 5x 0.1 mL
NR1D1 (Nuclear Receptor Subfamily 1, Group D, Member 1, EAR1, THRA1, THRAL, ear-1, hRev) (MaxLight 750)
Ask
View Details 
E45H00784-2 20 µg
Synaptotagmin 3 (SYT3) (NM_001160329) Human Over-expression Lysate
Ask
View Details